Search results for "I-h"

showing 10 items of 184 documents

Q fever: a new ocular manifestation

2011

P Udaondo1,3, S Garcia-Delpech1,2, D Salom1,2, M Garcia-Pous1, M Diaz-Llopis1,21Department of Ophthalmology, Nuevo Hospital Universitario y Politecnico La Fe, Valencia, Spain; 2Faculty of Medicine, Universitat de València, Valencia, Spain; 3Universidad Cardenal Herrera CEU, Valencia, SpainAbstract: Q Fever is a zoonosis caused by Coxiella burnetii. Ocular manifestations are rare in this infection. We describe the case of a man complaining of an intense retro-orbital headache, fever, arthralgia, and bilateral loss of vision, who showed an anterior uveitis accompanied by exudative bilateral inferior retinal detachment and optic disk edema. At the beginning, a Vogt–Koyanag…

Doxycyclineexudative retinal detachmentmedicine.medical_specialtybiologyVkh syndromebusiness.industryPanuveitispanuveitisRetinal detachmentQ feverCase ReportExudative retinal detachmentRE1-994Coxiella burnetiibiology.organism_classificationmedicine.diseaseVogt-Koyanagi-Harada syndromeComplete resolutioneye diseasesOphthalmologyOphthalmologymedicinebusinessQ fevermedicine.drugClinical Ophthalmology
researchProduct

Coupling of the antiviral agent zidovudine to polyaspartamide and in vitro drug release studies.

1998

A macromolecular prodrug of the known antiretroviral agent zidovudine and alpha, beta-poly(N-2-hydroxyethyl)-DL-aspartamide (PHEA) was synthesized. A succinic spacer was present between the polymer and the drug, and 1,1'-carbonyldiimidazole was used as the coupling agent. In vitro drug release studies at pH 1.1, 5.5 and 7.4 indicated that limited amounts of intact drug were released from the conjugate. At pH 1.1 and 7.4 succinylzidovudine was released, and this was hydrolysed to give free zidovudine. In the presence of alpha-chymotrypsin, zidovudine was released preferentially in comparison with the succinyl derivative. The amounts of released zidovudine and succinylzidovudine were greater …

DrugActive ingredientDrug CarriersChemistryAnti-HIV Agentsmedia_common.quotation_subjectHydrolysisPharmaceutical ScienceProdrugPharmacologyHydrogen-Ion ConcentrationIn Vitro TechniquesIn vitroZidovudinemedicineLiberationChymotrypsinHumansProdrugsDrug carrierPeptidesZidovudinemedia_commonmedicine.drugConjugateJournal of controlled release : official journal of the Controlled Release Society
researchProduct

Biowaiver monographs for immediate-release solid oral dosage forms: Zidovudine (azidothymidine).

2012

Literature data on the properties of zidovudine relevant to waiver of in vivo bioequivalence (BE) testing requirements for the approval of immediate-release (IR) solid oral dosage forms containing zidovudine alone or in combination with other active pharmaceutical ingredients (APIs) are reviewed. Solubility, dissolution, and permeability data for zidovudine, along with its dosing schedule, therapeutic index and pharmacokinetic properties, and reports related to BE/bioavailability were all taken into consideration. Data for solubility and permeability suggest that zidovudine belongs to Class I according to the Biopharmaceutics Classification System. Also, zidovudine is not a narrow therapeut…

DrugAnti-HIV Agentsmedia_common.quotation_subjectPharmaceutical ScienceExcipientAdministration OralHIV InfectionsPharmacologyBioequivalenceDosage formPermeabilityCell LineExcipientsZidovudineDogsPharmacokineticsBIOEQUIVALÊNCIAMedicineAnimalsHumansmedia_commonActive ingredientbusiness.industryBiopharmaceutics Classification SystemSolubilityTherapeutic EquivalencyCaco-2 CellsbusinessZidovudinemedicine.drugJournal of pharmaceutical sciences
researchProduct

Biowaiver monographs for immediate release solid oral dosage forms: efavirenz.

2013

Literature data pertaining to the decision to allow a waiver of in vivo bioequiv- alence testing for the approval of immediate-release (IR) solid oral dosage forms containing efavirenz as the only active pharmaceutical ingredient (API) are reviewed. Because of lack of conclusive data about efavirenz's permeability and its failure to comply with the "high solu- bility" criteria according to the Biopharmaceutics Classification System (BCS), the API can be classified as BCS Class II/IV. In line with the solubility characteristics, the innovator product does not meet the dissolution criteria for a "rapidly dissolving product." Furthermore, product variations containing commonly used excipients …

DrugCyclopropanesEfavirenzTime FactorsAnti-HIV Agentsmedia_common.quotation_subjectChemistry PharmaceuticalPharmaceutical ScienceAdministration OralBiological AvailabilityPharmacologyDosage formBiopharmaceuticschemistry.chemical_compoundInnovatorAnimalsHumansRegulatory scienceImmediate releasemedia_commonActive ingredientChemistryBiopharmaceutics Classification SystemBenzoxazinesSolubilityTherapeutic EquivalencyAlkynesJournal of pharmaceutical sciences
researchProduct

Monoclonal antibodies with subnanomolar affinity to tenofovir for monitoring adherence to antiretroviral therapies: from hapten synthesis to prototyp…

2020

Approximately 32 million people have died of HIV infection since the beginning of the outbreak, and 38 million are currently infected. Among strategies adopted by the Joint United Nations Programme on HIV/AIDS to end the AIDS global epidemic, the treatment, diagnosis, and viral suppression of the infected subjects are considered crucial for HIV prevention and transmission. Although several antiretroviral (ARV) drugs are successfully used to manage HIV infection, their efficacy strictly relies on perfect adherence to the therapy, which is seldom achieved. Patient supervision, especially in HIV-endemic, low-resource settings, requires rapid, easy-to-use, and affordable analytical tools, such …

DrugTenofovirAnti-HIV Agentsmedicine.drug_classmedia_common.quotation_subjectBiomedical EngineeringEnzyme-Linked Immunosorbent AssayHIV InfectionsMonoclonal antibody01 natural sciencesMice03 medical and health sciences0302 clinical medicineAcquired immunodeficiency syndrome (AIDS)medicineAnimalsHumansGeneral Materials Science030212 general & internal medicineTenofovirmedia_commonImmunoassaybiologyTransmission (medicine)business.industry010401 analytical chemistryAntibodies MonoclonalGeneral ChemistryGeneral Medicinemedicine.diseaseVirology0104 chemical sciencesImmunizationPoint-of-Care Testingbiology.proteinDrug MonitoringAntibodybusinessHaptenmedicine.drug
researchProduct

Guava (Psidium guajava L.) Leaf Extract as Bioactive Substances for Anti-Androgen and Antioxidant Activities

2022

Leaves of guava (Psidium guajava L.) have been used in Thai folk medicine without any supporting evidence as a traditional herbal remedy for hair loss. Androgenetic alopecia (AGA) is chronic hair loss caused by effects of androgens in those with a genetic predisposition, resulting in hair follicle miniaturization. Our objectives were to provide the mechanistic assessment of guava leaf extract on gene expressions related to the androgen pathway in well-known in vitro models, hair follicle dermal papilla cells (HFDPC), and human prostate cancer cells (DU-145), and to determine its bioactive constituents and antioxidant activities. LC-MS analysis demonstrated that the main components of the et…

EcologyPlant SciencePlantes medicinalsEcology Evolution Behavior and Systematicsandrogenetic alopecia; anti-hair loss; dermal papilla; DU-145; guava; hair follicle; hair growth; HFDPC; 5α-reductase; <i>SRD5A</i>Plants; Volume 11; Issue 24; Pages: 3514
researchProduct

Evaluating the Performance of Real Time Videoconferencing in Ad Hoc Networks Through Emulation

2008

The validation of new video protocols and applications for mobile ad hoc networks in a real environment is an important task. In this work we present Castadiva, a test-bed architecture that allows validating software solutions for ad hoc networks using low-cost, off-the-shelf devices and open source software. We use this tool to test a videocall using the OLSR protocol in different scenarios, varying the number of hops between the caller and the receiver. The results obtained in this paper show that, for an ad hoc network with a large number of hops, the quality of videocalls suffers a significant degradation even in the absence of mobility.

EmulationAd hoc testingVehicular ad hoc networkAdaptive quality of service multi-hop routingWireless ad hoc networkbusiness.industryComputer scienceDistributed computingComputerSystemsOrganization_COMPUTER-COMMUNICATIONNETWORKSMobile ad hoc networkAd hoc wireless distribution serviceOptimized Link State Routing ProtocolbusinessComputer network2008 22nd Workshop on Principles of Advanced and Distributed Simulation
researchProduct

A water-soluble hexa-peri-hexabenzocoronene: synthesis, self-assembly and role as template for porous silica with aligned nanochannels

2005

A water-soluble hexa-peri-hexabenzocoronene was prepared and shown to undergo ordered columnar self-assembly either in water solution or bulk and therefore served as template for the fabrication of porous silica with aligned nanochannels.

FabricationMaterials scienceMetals and AlloysHexa-peri-hexabenzocoroneneNanotechnologyGeneral ChemistryCatalysisSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsWater solubleMaterials ChemistryCeramics and CompositesSelf-assemblyPorosityChem. Commun.
researchProduct

A QSAR study investigating the potential anti-HIV-1 effect of some acyclovir and ganciclovir analogs

2009

A QSAR study, involving the use of calculated physical-chemical properties (TSAR TM ), and the use of a neural network approach (TSAR TM ), has been performed on the potential anti-HIV-1 activity of a series of Acyclovir and Ganciclovir analogs. Model obtained allows reliable predictions for the anti-HIV-1 activity of these derivatives, and showed that the presence of the Ganciclovir chain in triazolopyrrolopyrimidine and pyrimidopyrrolopyrimidine series seems to increase the antiviral effect.

GanciclovirAnti hiv 1Quantitative structure–activity relationshipStereochemistryChemistryOrganic ChemistrymedicineQSAR neural network BMLR anti-HIV-1 activityvirus diseasesPharmacologySettore CHIM/08 - Chimica Farmaceuticamedicine.drug
researchProduct

Anti-HLA immunization of patients qualified for lung transplantation – Single center study

2021

For lung transplantation, the presence of donor-specific anti-HLA antibodies (DSA) is an important factor of antibody-mediated rejection (AMR) in its hyperacute, acute or chronic form during long-term follow up. The aim of the study was to assess the allosensitization of Polish patients qualified for a lung transplantation in our center. A retrospective study of 161 potential lung allograft recipients, also of 31 patients transplanted in the Uni-versity Hospital of Gdansk, between June 2018 and December 2020 were performed. 121 potential recipients were thoroughly tested for immunization status before eventual lung transplantation. SAB-testing, PRA-CDC and vPRA assessment, and HLA typing we…

Graft RejectionAnti-HLA sensitizationTransplantationHistocompatibility TestingImmunologyKidney TransplantationTransplant immunologyHLA AntigensIsoantibodiesHumansImmunology and AllergyImmunizationLung TransplantationRetrospective StudiesTransplant Immunology
researchProduct